Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse [Phase 3]
Phase 3 trial comparing Caelyx (liposomal doxorubicin) plus carboplatin with paclitaxel plus carboplatin in late-relapsed epithelial ovarian…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update covers a phase 1/2 study of combination chemotherapy with peripheral stem cell transplantation for recurrent or p…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 clinical trial update describes a study of docetaxel plus carboplatin for patients with Stage III or IV ovarian, fallopian tube…
-
CLINICAL_TRIALS withdrawal · 2013-12-20Clinical Trial Update: Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
A Phase 2 safety and efficacy study of gemcitabine plus bevacizumab for platinum-resistant ovarian, fallopian tube, or primary peritoneal ca…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
A Phase 2 study evaluating CP-547,632 in recurrent or persistent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-12-18Clinical Trial Update: Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission [Phase 1, Phase 2]
Withdrawal of a Phase 1/2 trial evaluating a cancer vaccine therapy in combination with the IDO1 inhibitor epacadostat (INCB024360) for epit…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing early chemotherapy based on CA 125 levels versus delayed chemotherapy in recurrent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating Hu3S193 in women with ovarian epithelial, primary peritoneal, or fallopian tube cancer has completed, and results h…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update of temsirolimus in refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer; results po…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating irinotecan in patients with refractory ovarian epithelial, primary peritoneal, or fallopian tube cancer …
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update of a monoclonal antibody therapy for ovarian, fallopian tube, and primary peritoneal cancer sponsored by AltaR…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating a monoclonal antibody therapy in patients with residual disease after surgery and chemotherapy for stage I…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study [NA]
A feasibility trial evaluating yoga to improve quality of life in patients with ovarian, fallopian tube, or primary peritoneal cancer receiv…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update investigating a gene therapy for women with refractory or relapsed ovarian epithelial cancer, fallopian tube c…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) in combination with docetaxel in ovarian, fallopian tube, and primary peritoneal cancers has …
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2, single-arm trial evaluating BSI-201 in BRCA-associated advanced epithelial ovarian cancer, fallopian tube cancer, and primary perit…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
This clinical trial update describes a laboratory study aimed at predicting tumor response to chemotherapy in patients with fallopian tube c…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating carboplatin and paclitaxel with or without bevacizumab in advanced ovarian epithelial, primary peritoneal, or fallo…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating two different schedules of carboplatin, paclitaxel, and gemcitabine with surgery for newly diagnosed adv…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing tamoxifen to thalidomide in women with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer [NA]
Clinical trial update for hyperthermic intraperitoneal chemotherapy using carboplatin in first recurrence ovarian cancer; study terminated w…
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
A Phase 3 trial comparing erlotinib to observation in patients who completed first-line chemotherapy for ovarian, fallopian tube, or primary…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of Bryostatin 1 in combination with Cisplatin for advanced recurrent or residual ovarian epithelial, fallopian tube, or primar…